IMTX
Price
$10.54
Change
+$0.22 (+2.13%)
Updated
Nov 19, 01:46 PM (EDT)
Capitalization
1.25B
126 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$4.16
Change
-$0.12 (-2.80%)
Updated
Nov 19, 02:05 PM (EDT)
Capitalization
238.25M
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMTX vs VYGR

Header iconIMTX vs VYGR Comparison
Open Charts IMTX vs VYGRBanner chart's image
Immatics
Price$10.54
Change+$0.22 (+2.13%)
Volume$100
Capitalization1.25B
Voyager Therapeutics
Price$4.16
Change-$0.12 (-2.80%)
Volume$500
Capitalization238.25M
IMTX vs VYGR Comparison Chart in %
IMTX
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMTX vs. VYGR commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (IMTX: $10.32 vs. VYGR: $4.28)
Brand notoriety: IMTX and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 84% vs. VYGR: 69%
Market capitalization -- IMTX: $1.25B vs. VYGR: $238.25M
IMTX [@Biotechnology] is valued at $1.25B. VYGR’s [@Biotechnology] market capitalization is $238.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 3 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • IMTX’s TA Score: 3 bullish, 5 bearish.
  • VYGR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than IMTX.

Price Growth

IMTX (@Biotechnology) experienced а +12.31% price change this week, while VYGR (@Biotechnology) price change was +0.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was -5.78%, and the average quarterly price growth was +64.73%.

Reported Earning Dates

IMTX is expected to report earnings on Mar 25, 2026.

VYGR is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($1.26B) has a higher market cap than VYGR($238M). IMTX has higher P/E ratio than VYGR: IMTX (27.61) vs VYGR (6.00). IMTX YTD gains are higher at: 45.162 vs. VYGR (-24.427). IMTX has higher annual earnings (EBITDA): -58.05M vs. VYGR (-119.18M). IMTX has more cash in the bank: 478M vs. VYGR (43.9M). IMTX has less debt than VYGR: IMTX (17.1M) vs VYGR (40.2M). IMTX has higher revenues than VYGR: IMTX (130M) vs VYGR (42.6M).
IMTXVYGRIMTX / VYGR
Capitalization1.26B238M527%
EBITDA-58.05M-119.18M49%
Gain YTD45.162-24.427-185%
P/E Ratio27.616.00460%
Revenue130M42.6M305%
Total Cash478M43.9M1,089%
Total Debt17.1M40.2M43%
FUNDAMENTALS RATINGS
IMTX vs VYGR: Fundamental Ratings
IMTX
VYGR
OUTLOOK RATING
1..100
7469
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9295
PRICE GROWTH RATING
1..100
3858
P/E GROWTH RATING
1..100
548
SEASONALITY SCORE
1..100
3750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (45) in the Biotechnology industry is in the same range as IMTX (72) in the null industry. This means that VYGR’s stock grew similarly to IMTX’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IMTX (100) in the null industry. This means that VYGR’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's SMR Rating (92) in the null industry is in the same range as VYGR (95) in the Biotechnology industry. This means that IMTX’s stock grew similarly to VYGR’s over the last 12 months.

IMTX's Price Growth Rating (38) in the null industry is in the same range as VYGR (58) in the Biotechnology industry. This means that IMTX’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (8) in the Biotechnology industry is somewhat better than the same rating for IMTX (54) in the null industry. This means that VYGR’s stock grew somewhat faster than IMTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMTXVYGR
RSI
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
79%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
IMTX
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STVTX10.45N/A
N/A
Virtus Ceredex Large-Cap Value Equity I
KTCCX16.01N/A
N/A
DWS Science and Technology C
GCEUX102.33N/A
N/A
Green Century Equity Institutional
GSAFX28.00N/A
N/A
Goldman Sachs China Equity R6
JHUKX40.40-0.36
-0.88%
JPMorgan Emerging Markets Equity R4

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+8.99%
IDYA - IMTX
55%
Loosely correlated
+1.08%
VYGR - IMTX
52%
Loosely correlated
+4.26%
OCUL - IMTX
51%
Loosely correlated
-1.09%
SYRE - IMTX
51%
Loosely correlated
-1.07%
CGON - IMTX
51%
Loosely correlated
+3.15%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+4.26%
RGNX - VYGR
54%
Loosely correlated
+0.94%
KYMR - VYGR
54%
Loosely correlated
+0.43%
IMTX - VYGR
53%
Loosely correlated
+8.99%
BDTX - VYGR
49%
Loosely correlated
-1.12%
XNCR - VYGR
49%
Loosely correlated
+2.62%
More